|
1）Inoue K, Kuwana H, Shimamura Y, et al. Cisplatin-induced macroautophagy occurs prior to apoptosis in proximal tubules in vivo. Clin Exp Nephrol. 2010; 14: 112-22
|
|
|
|
2）Jiang M, Liu K, Luo J, et al. Autophagy is a renoprotective mechanism during in vitro hypoxia and in vivo ischemia-reperfusion injury. Am J Pathol. 2010; 176: 1181-92
|
|
|
|
|
|
3）Bolisetty S, Traylor AM, Kim J, et al. Heme oxygenase-1 inhibits renal tubular macroautophagy in acute kidney injury. J Am Soc Nephrol. 2010; 21: 1702-12
|
|
|
|
|
|
4）Gozuacik D, Bialik S, Raveh T, et al. DAP-kinase is a mediator of ER stress-induced caspase activation and autophagic cell death. Cell Death Differ. 2008; 15: 1875-86
|
|
|
|
|
|
5）Kawakami T, Inagi R, Takano H, et al. Endoplasmic reticulum stress induces autophagy in renal proximal tubular cells. Nephrol Dial Transplant. 2009; 24: 2665-72
|
|
|
|
|
|
6）Periyasamy-Thandavan S, Jiang M, Wei Q, et al. Autophagy is cytoprotective during cisplatin injury of renal proximal tubular cells. Kidney Int. 2008; 74: 631-40
|
|
|
|
|
|
7）Isaka Y, Suzuki C, Abe T, et al. Bcl-2 protects tubular epithelial cells from ischemia/reperfusion injury by dual mechanism. Transplant Proc. 2009; 41: 52-4
|
|
|
|
|
|
8）Yang C, Kaushal V, Shah SV, et al. Autophagy is associated with apoptosis in cisplatin injury to renal tubular epithelial cells. Am J Physiol Renal Physiol. 2008; 294: F777-87
|
|
|
|
|
|
9）Pallet N, Bouvier N, Legendre C, et al. Autophagy protects renal tubular cells against cyclosporine toxicity. Autophagy. 2008; 4: 783-91
|
|
|
|
|
|
10）Jiang M, Liu K, Luo J, et al. Autophagy is a renoprotective mechanism during in vitro hypoxia and in vivo ischemia-reperfusion injury. Am J Pathol. 2010; 176: 1181-92
|
|
|
|
|
|
11）Kimura T, Takabatake Y, Takahashi A, et al. Autophagy protects the proximal tubule from degeneration and acute ischemic injury. J Am Soc Nephrol. 2011; 22: 902-13
|
|
|
|
|
|
12）Mayer-Schwesinger C, Lange C, Broecker V, et al. Bone marrow-derived progenitor cells do not contribute to podocyte turnover in the puromycin aminoglycoside and renal ablation models in rats. Am J Pathol. 2011; 178: 494-9
|
|
|
|
|
|
13）Asanuma K, Tanida I, Shirato I, et al. MAP-LC3, a promising autophagosomal marker, is processed during the differentiation and recovery of podocytes from PAN nephrosis. FASEB J. 2003; 17: 1165-7
|
|
|
|
|
|
14）Sato S, Kitamura H, Adachi A, et al. Two types of autophagy in the podocytes in renal biopsy specimens: ultrastructual study. J Submicrosc Cytol Pathol. 2006; 38: 167-74
|
|
|
|
|
|
15）Hartleben B, Goedel M, Mayer-Schwesinger C, et al. Autophagy influences glomerular disease susceptibility and maintains podocyte homeostasis in aging mice. J Clin Invest. 2010; 120: 1084-96
|
|
|
|
|
|
16）Wang L, Hong Q, Lv Y, et al. Autophagy can repair endoplasmic reticulum stress damage of the passive Heymann nephritis model as revealed proteomics analysis. J Proteomics. 2012; 75: 3866-75
|
|
|
|
|
|
17）Anju Y, Sridevi V, Shitij A, et al. ANG II promotes autophagy in podocytes. Am J Physiol Cell Physiol. 2010; 299: 488-96
|
|
|
|
|
|
18）Riediger F, Quack I, Qadri F, et al. Prorenin receptor is essential for podocyte autophagy and survival. J Am Soc Nephrol. 2011; 22: 2193-202
|
|
|
|
|
|
19）Hallman MA, Zhuang S, Schnellmann RG. Regulation of dedifferentiation and redifferentiation in renal proximal tubular cells by the epidermal growth factor receptor. J Pharmacol Exp Ther. 2008; 325: 520-8
|
|
|
|
|
|
20）Zhuang S, Yan Y, Han J, et al. p38 kinase-mediated transactivation of the epidermal growth factor receptor is required for dedifferentiation of renal epithelial cells after oxidant injury. J Biol Chem. 2005; 280: 21036-42
|
|
|
|
|
|
21）Li Y, Yang J, Luo JH, et al. Tubular epithelial cell dedifferentiation is driven by the Helix - Loop - Helix transcriptional inhibitor Id1. J Am Soc Nephrol. 2007; 18: 449-60
|
|
|
|
|
|
22）Chen J, Chen JK, Harris RC. Angiotensin II induces epithelial - to - mesenchymal transition in renal epithelial cells through reactive oxygen species/Src/caveolin-mediated activation of an epidermal growth factor receptor - extracellular signal - regulated kinase signaling pathway. Mol Cell Biol. 2012; 32: 981-91
|
|
|
|
|
|
23）Xiong M, Jiang L, Zhou Y, et al. The miR-200 family regulates TGF-β1-induced renal tubular epithelial to mesenchymal transition through Smad pathway by targeting ZEB1 and ZEB2 expression. Am J Physiol Renal Physiol. 2012; 302: 369-79
|
|
|
|
|
|
24）Zhuang S, Duan M, Yan Y. Src family kinases regulate renal epithelial dedifferentiation through activation of EGFR/PI3K signaling. J Cell Physiol. 2012; 227: 2138-44
|
|
|
|
|
|
25）Hader C, Marlier A, Cantley L. Mesenchymal-epithelial transition in epithelial response to injury: the role of Foxc2. Oncogene. 2010; 29: 1031-40
|
|
|
|
|
|
26）Matsuda H, Lavoie JL, Gaboury L, et al. HCaRG accelerates tubular repair after ischemic kidney injury. J Am Soc Nephrol. 2011; 22: 2077-89
|
|
|
|
|
|
27）Wiggins RC. The spectrum of podocytopathies: A unifying view of glomerular diseases. Kidney Int. 2007; 71: 1205-14
|
|
|
|
|
|
28）Wharram BL, Goyal M, Wiggins JE, et al. Podocyte depletion causes glomerulosclerosis: Diphtheria toxin-induced podocyte depletion in rats expressing human diphtheria toxin receptor transgene. J Am Soc Nephrol. 2005; 16: 2941-52
|
|
|
|
|
|
29）Prodromidi EI, Poulsom R, Jeffery R, et al. Bone marrow-derived cells contribute to podocyte regeneration and amelioration of renal disease in a mouse model of Alport syndrome. Stem Cells. 2006; 24: 2448-55
|
|
|
|
|
|
30）Sugimoto H, Mundel TM, Sund M, et al. Bone-marrow-derived stem cells repair basement membrane collagen defects and reverse genetic kidney disease. Proc Natl Acad Sci USA. 2006; 103: 7321-6
|
|
|
|
|
|
31）Becker JU, Hoerning A, Schmid KW, et al. Immigrating progenitor cells contribute to human podocyte turnover. Kidney Int. 2007; 72: 1468-73
|
|
|
|
|
|
32）Ronconi E, Sagrinati C, Angelotti ML, et al. Regeneration of glomerular podocytes by human renal progenitors. J Am Soc Nephrol. 2010; 20: 322-32
|
|
|
|
|
|
33）Lasagni L, Ballerini L, Angelotti ML, et al. Notch activation differentially regulates renal progenitors proliferation and differentiation toward the podocyte lineage in glomerular disorders. Stem Cells. 2010; 28: 1673-85
|
|
|
|
|
|
34）Shkreli M, Sarin KY, Pech MF, et al Reversible cell cycle entry in adult kidney podocytes through regulated control of telomerase and Wnt signaling. Nat Med. 2012; 18: 111-9
|
|
|
|
|